Steroid-sparing Therapy (Olanzapine) Versus Dexamethasone-based Therapy for Chemotherapy-induced Nausea and Vomiting
The Efficacy of Steroid-Sparing Anti-Emetic Therapy in Patients Treated With High or Moderate Emetogenic Chemotherapy; Single Center Non-Inferiority Open Label Randomized Controlled Trial
Sponsor: The Guthrie Clinic
Terminated
Study stopped due to lower than expected accrual.
Other terminated trials from The Guthrie Clinic
Other Chemotherapy-induced Nausea and Vomiting trials with similar outcome
This PHASE4 trial investigates Chemotherapy-induced Nausea and Vomiting and is currently terminated or withdrawn. The Guthrie Clinic leads this study, which shows 8 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Nov 2025 — Present [monthly]
Terminated PHASE4
Status: Recruiting → Terminated
-
Feb 2025 — Nov 2025 [monthly]
Recruiting PHASE4
-
Sep 2024 — Feb 2025 [monthly]
Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE4
-
Mar 2024 — Jul 2024 [monthly]
Recruiting PHASE4
▶ Show 3 earlier versions
-
Mar 2023 — Mar 2024 [monthly]
Recruiting PHASE4
-
Feb 2023 — Mar 2023 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Nov 2022 — Feb 2023 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- The Guthrie Clinic
For direct contact, visit the study record on ClinicalTrials.gov .